Delivery Order SPE2DB20D3103-SPE2DB25FM2T5

Award Date 1/9/25
Potential Completion Date 1/10/25
Potential Value $7.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) by the Defense Logistics Agency (DLA) Troop Support Medical is for the delivery of AIMOVIG 70 MG/ML autoinjectors. The $1,745.07 fixed-price contract has a completion date of November 8, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The single-award indefinite delivery contract (IDC) is with the Defense Logistics Agency (DLA) Troop Support Medical and is valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to...
The federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML with a firm fixed price of $4,611.36. The contract, awarded by the Defense Logistics Agency (DLA), has an ultimate completion date of November 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC encompasses a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,150.81 delivery order contract is for the provision of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty medication. The contract has a firm fixed price and runs through December 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of the medication Aimovig 140 mg/ml autoinjector. The contract has a ceiling value of $1,404.75 and runs through December 5, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Aimovig 70 mg/ml autoinjector medication. The $6,097.71 Firm Fixed Price delivery order was issued by the Defense Logistics Agency (DLA) on August 18, 2021, with a completion date of August 19, 2021. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $11,229.48 Firm Fixed Price delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract. The contract is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a prescription medication, with a performance period through December 20, 2024. Amerisourcebergen holds a $999,999,999 IDC with the DLA for providing a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Aimovig 140 mg/ml autoinjectors to the Defense Logistics Agency (DLA). The single-award Indefinite Delivery Contract (IDC) with the DLA is valued at up to $999,999,999.00 through December 31, 2025 and serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense...
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distribution company, for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML medication to the Defense Logistics Agency (DLA). The delivery order-based contract has a ceiling value of $3,620.96 and an ultimate completion date of July 12, 2024. The contract is a firm fixed price, with no set-aside designation. Amerisourcebergen holds a larger, single-award Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of AIMOVIG 70 MG/ML autoinjector medications. The $2,316.34 firm-fixed-price delivery order has a completion date of July 18, 2022. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM2T5
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract has a ceiling value of $7,330.41 and runs through January 10, 2025. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation indicated.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 4/10/25, 11:49 AM